{"as_of":"2026-08-19T20:26:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:bf6b372381756fc7dcf4d4eb1ade51f4c94cafceea8343f58ceb170f0313d272","coverage":[{"denominator":19,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":19,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-12T12:48:30.237887Z","state":"measured"},{"denominator":19,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":19,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-19T06:32:44.657259+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2411.16938/citation-record","integrity":"/paper/2411.16938/integrity","json":"/paper/2411.16938/citation-record.json","paper":"/paper/2411.16938"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.691734Z","title":"The use and limitations of the fragility index in the interpretation of clinical trial findings","venue":null,"work_id":"f9242679-4efe-400f-8184-330cb0fb2290","year":2020},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.506416Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:4228635bf27c48b296a308633a49d4a5957e58bf7ee0e178d7cae84350a5bcdc","observation_id":"2f135357-70a6-43ba-9d98-af229a14155e","resolution":{"observed_at":"2026-08-12T12:48:31.755776Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.637661Z","title":"Fragility indices for only sufficiently likely modifications","venue":null,"work_id":"b8c497d8-9e87-49c3-9df6-dc70a2822d1c","year":2021},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.525356Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:1b8988917020054019fc4b2b9fe402eec5bcdafe9945b468adf092f051b9c65f","observation_id":"f1062569-b634-41f8-9acc-d23578323e28","resolution":{"observed_at":"2026-08-12T12:48:31.664763Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.589598Z","title":"Survival-inferred fragility index of phase 3 clinical trials evaluating immune checkpoint inhibitors","venue":null,"work_id":"89d3a29f-aa55-4989-9728-82bc1b1c2004","year":2020},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.556876Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:cd4d85b1452a24a79f15b220dc10f560523f5d924c5add396d30aa49d8f1e275","observation_id":"0525fb96-cc40-4768-b6ec-b844dee4e6c6","resolution":{"observed_at":"2026-08-12T12:48:31.611931Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.527053Z","title":"It's time to talk about ditching statistical significance","venue":null,"work_id":"454dd96d-1cea-4d84-bdfd-68fc8331867f","year":2019},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.593384Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:0f78753077c1d3322492bce0d00b5b1be163248a9dae67cbab04c757b185b665","observation_id":"8dae6f34-1e72-45a1-baa2-d74f59b3d653","resolution":{"observed_at":"2026-08-12T12:48:31.554765Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.459551Z","title":"Truncated life tests in the exponential case","venue":null,"work_id":"3e753cb5-21ac-49cb-b97e-92fa861c7b6d","year":1954},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.613122Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:3889f5a570429cd51deda40a3b0af29cb83adcf1a82f1c4e659b1a2432f9bd7c","observation_id":"78cb7e2a-dff9-4eeb-ab43-1b3dc66cc245","resolution":{"observed_at":"2026-08-12T12:48:31.488812Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.376289Z","title":"Life testing","venue":null,"work_id":"bf8af670-6a28-46fc-90d3-2579febb748e","year":1953},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.631900Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:24af01e39e3e8339fa8198ba38a1b1c611332c7451533e49c2fe5025a88aa553","observation_id":"0f4cdaa6-439b-42d9-a85d-bb752b212436","resolution":{"observed_at":"2026-08-12T12:48:31.429115Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.266658Z","title":"Some theorems relevant to life testing from an exponential distribution","venue":null,"work_id":"9cb469c8-6246-49cf-9bab-42bfd816afb4","year":1954},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.652510Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:ef82a264252ecc0541f38332cec6232fe18314f23dfcd0137878a93a2cbe6347","observation_id":"cf995f81-2c52-45de-81ec-303c46782f64","resolution":{"observed_at":"2026-08-12T12:48:31.302352Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.223639Z","title":"Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma","venue":null,"work_id":"926331fe-e5af-4f26-8987-67cf593043e3","year":2019},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.683089Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:90b2182c601c82a8df6c8fb957728066e058bb30cf995e8400ae437de9099cff","observation_id":"946b6a41-3525-4b76-a38a-e0e8797c1cb3","resolution":{"observed_at":"2026-08-12T12:48:31.238104Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.166125Z","title":"Fragility index and fragility quotient in randomized clinical trials","venue":null,"work_id":"dfeb31ef-c7d0-4b64-b019-d1a363c2bfdb","year":2023},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.748800Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:47cb3eab07ec8987394e8739237e96d9f8ffe1565acf2e0cf6f7879ae3c5dcd8","observation_id":"66df794f-2953-44ef-a089-cce0ffa1d2ea","resolution":{"observed_at":"2026-08-12T12:48:31.205198Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.086291Z","title":"The robustness index: going beyond statistical significance by quantifying fragility","venue":null,"work_id":"736914bb-f2f9-4781-bc4f-f06d3edd200a","year":2023},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.795767Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:c3fbb4a9086927944fb7655940479832abb605f6a624b722f65be439c046bcff","observation_id":"746c7c1b-1d1e-4a00-ad94-aa0dfb8e0e98","resolution":{"observed_at":"2026-08-12T12:48:31.129429Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:31.010505Z","title":"A phase ii trial of an alternative schedule of palbociclib and embedded serum tk1 analysis","venue":null,"work_id":"c708d77c-62b1-4e2e-a813-8288440588b8","year":2022},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.823927Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:403f13b1c7afd21926215ae0d8bef4e1555631430814b1aad1a2871446ed9f57","observation_id":"3665090c-961e-4889-b5ca-dbbe337c1383","resolution":{"observed_at":"2026-08-12T12:48:31.037332Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.917137Z","title":"Assessing and visualizing fragility of clinical results with binary outcomes in r using the fragility package","venue":null,"work_id":"6b5b41e1-f95f-4acd-bedb-92c8bcbfb93e","year":2022},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.895868Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:64b2c81bf9edaf32bd5a7acd8fd236f4f581911e30ba2cf4e744ad62a94d60b9","observation_id":"52029434-9cc8-4f7c-92e0-feff917c52d3","resolution":{"observed_at":"2026-08-12T12:48:30.943988Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.839468Z","title":"The fragility of phase iii trials in oncology","venue":null,"work_id":"29cd46d7-c182-49c6-b52e-4e6b7e14ec79","year":2024},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:29.964683Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:1f123d974ecc941624e377c87a1baed681e69030697988c63145333d5764e52d","observation_id":"bc8e8459-e8d6-4b0a-bf25-b1562167d5c2","resolution":{"observed_at":"2026-08-12T12:48:30.875510Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.793561Z","title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","venue":null,"work_id":"5192c654-e7c8-4a9a-b6fc-e13c2b84c7f2","year":2014},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.025350Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:b9eda88f63cdad1f62f16c653b4ecc84fbb89c405d150201dcf42d60f6db813a","observation_id":"d204879b-6669-4d82-8795-cec2034a0b0d","resolution":{"observed_at":"2026-08-12T12:48:30.816320Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.737911Z","title":"Statistical fragility of findings from randomized phase 3 trials in pediatric oncology., 2024","venue":null,"work_id":"68d4bcc0-ecb0-40e5-9cee-d06117e9362e","year":2024},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.064247Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:be4a0b68014a06b2174dff9e485f0e55ec751a8b79cf060ab8b64ec98ea254da","observation_id":"6d94f441-1277-4a24-849a-5fbfc8fb59e3","resolution":{"observed_at":"2026-08-12T12:48:30.761155Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.634404Z","title":"Dismantling the fragility index: a demonstration of statistical reasoning","venue":null,"work_id":"0ffe88d7-a408-4c0d-8a3b-dc67529a66e0","year":2020},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.091555Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:a75c70ebd92647c4dcc673a4e730397f1ce7e158f74b910fbdb16e12d6189f57","observation_id":"b56c7f5f-bc1f-4647-a040-6addc75ca3e0","resolution":{"observed_at":"2026-08-12T12:48:30.703556Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.486966Z","title":"The fragility index in multicenter randomized controlled critical care trials","venue":null,"work_id":"320bda33-da3a-4e00-9473-e5b6a5e6ce9f","year":2016},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.131814Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:2b672eba0352762c82e789d253c8fd718316e3ff04ccc6582595f160f79c17d8","observation_id":"dbedd8ff-2dfb-439e-a31b-79c07f738ff5","resolution":{"observed_at":"2026-08-12T12:48:30.552735Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.386040Z","title":"The fragility index in randomized clinical trials as a means of optimizing patient care","venue":null,"work_id":"2321e3dd-a750-4f9a-bbf1-046fc6e68f1d","year":2019},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.176699Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:cd80ddbf50c185a757819fe7fe7b95d084c0187952a23ad5f1e60db782f56714","observation_id":"aebc3148-634f-4f3d-82f6-0c41fca698f8","resolution":{"observed_at":"2026-08-12T12:48:30.444110Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T12:48:30.305100Z","title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index","venue":null,"work_id":"8116bbe8-daf5-4787-bc98-fe0306489be6","year":2014},"citing_paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-08-12T12:48:30.237887Z"},"links":{"citing_paper":"/paper/2411.16938"},"observation_digest":"sha256:cb7b8eb663c82fd8c4ef2cf3d76dc9b222b8eb8ad7044bf1583d73234e963f95","observation_id":"fabda033-e096-4896-a8ed-257e3d1f3e45","resolution":{"observed_at":"2026-08-12T12:48:30.348769Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2411.16938","last_updated":"2024-11-25T21:20:20Z","latest_version":1,"primary_category":"stat.ME","snapshot_observed_at":"2026-08-19T06:38:32.890932Z","submitted_at":"2024-11-25T21:20:20Z","title":"Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials"},"reference_resolution":{"displayed":19,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":0,"verified_exact":0,"verified_fuzzy":19},"total_outbound_references":19},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"thesis":"As of 19 August 2026, this Paper Citation Record lists 19 of 19 outbound references and 0 inbound Pith citation observations for arXiv:2411.16938."}